Stereotaxis (STXS): Price and Financial Metrics
Stereotaxis (STXS)
Today's Latest Price: $4.49 USD
Updated Jan 27 2:31pm
Add STXS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 188 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
STXS Stock Summary
- The ratio of debt to operating expenses for Stereotaxis Inc is higher than it is for about merely 17.44% of US stocks.
- STXS's price/sales ratio is 13.08; that's higher than the P/S ratio of 86.01% of US stocks.
- In terms of twelve month growth in earnings before interest and taxes, Stereotaxis Inc is reporting a growth rate of 57.15%; that's higher than 82.74% of US stocks.
- Stocks that are quantitatively similar to STXS, based on their financial statements, market capitalization, and price volatility, are FLDM, AEHR, ICAD, TUFN, and MBII.
- STXS's SEC filings can be seen here. And to visit Stereotaxis Inc's official web site, go to www.stereotaxis.com.
STXS Stock Price Chart Interactive Chart >
STXS Price/Volume Stats
| Current price | $4.49 | 52-week high | $5.58 |
| Prev. close | $4.74 | 52-week low | $1.70 |
| Day low | $4.31 | Volume | 213,665 |
| Day high | $4.69 | Avg. volume | 186,785 |
| 50-day MA | $4.74 | Dividend yield | N/A |
| 200-day MA | $4.12 | Market Cap | 330.85M |
Stereotaxis (STXS) Company Bio
Stereotaxis Inc. designs, manufactures, and markets advanced cardiology instrument control system for use in the cath lab that is used in the treatment of coronary artery disease and arrhythmias. The Company markets Stereotaxis System in the United States and Europe.
Loading social stream, please wait...